$1.23
In chiusura: Oct 30 EDT
$1.21
-0.02-1.63%
Pre-mercato: 5:45 PM EDT
Evogene segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Evogene utilizzando ordinamenti e filtri avanzati.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EVGN | Evogene | -$1.31 | -$0.41 | — | — | $1.80M | $650.00K | — | — | 11/20/2025 | |
| EVGN | Evogene | -$0.85 | -$0.63 | -$0.50 | 20.63% | $914.00K | $930.00K | $884.00K | -4.95% | 08/19/2025 | |
| EVGN | Evogene | -$0.76 | -$0.50 | -$0.38 | 24.00% | $4.19M | $4.42M | $2.44M | -44.71% | 05/21/2025 | |
| EVGN | Evogene | -$1.30 | -$0.73 | $0.06 | 108.22% | $578.00K | $3.62M | $1.61M | -55.50% | 03/06/2025 | |
| EVGN | Evogene | -$0.81 | -$1.01 | -$1.31 | -29.70% | $3.77M | $2.85M | $1.80M | -36.98% | 11/21/2024 | |
| EVGN | Evogene | -$1.68 | -$1.20 | -$1.06 | 11.67% | $654.00K | $800.00K | $914.00K | 14.25% | 08/22/2024 | |
| EVGN | Evogene | -$1.50 | -$0.90 | -$0.80 | 11.11% | $641.00K | $3.50M | $4.19M | 19.71% | 05/23/2024 | |
| EVGN | Evogene | -$0.70 | -$1.40 | -$1.30 | 7.14% | $660.00K | $910.00K | $578.00K | -36.48% | 03/07/2024 | |
| EVGN | Evogene | -$1.60 | -$1.60 | -$0.80 | 50.00% | $466.00K | $1.18M | $3.77M | 219.24% | 11/15/2023 | |
| EVGN | Evogene | -$2.10 | -$1.70 | -$1.70 | 0.00% | $312.00K | $880.00K | $654.00K | -25.68% | 08/17/2023 | |
| EVGN | Evogene | -$2.00 | -$1.60 | -$1.50 | 6.25% | $237.00K | $870.00K | $641.00K | -26.32% | 05/18/2023 | |
| EVGN | Evogene | -$1.80 | -$2.00 | -$0.70 | 65.00% | $311.00K | $420.00K | $660.00K | 57.14% | 03/09/2023 | |
| EVGN | Evogene | -$1.90 | $2.00 | -$1.60 | -180.00% | $151.00K | $100.00K | $466.00K | 366.00% | 11/17/2022 | |
| EVGN | Evogene | -$1.50 | -$1.70 | -$2.10 | -23.53% | $135.00K | $270.00K | $312.00K | 15.56% | 08/31/2022 | |
| EVGN | Evogene | -$1.70 | — | -$2.00 | — | $333.00K | — | $237.00K | — | 05/26/2022 | |
| EVGN | Evogene | -$2.50 | -$1.70 | -$1.80 | -5.88% | $351.00K | $270.00K | $311.00K | 15.19% | 03/10/2022 | |
| EVGN | Evogene | -$1.70 | -$1.70 | -$1.90 | -11.76% | $316.00K | $270.00K | $151.00K | -44.07% | 11/17/2021 | |
| EVGN | Evogene | -$1.70 | -$1.80 | -$1.50 | 16.67% | $298.00K | $300.00K | $135.00K | -55.00% | 08/11/2021 | |
| EVGN | Evogene | -$2.40 | — | -$1.70 | — | $75.00K | $300.00K | $333.00K | 11.00% | 05/26/2021 | |
| EVGN | Evogene | -$2.40 | — | -$2.50 | — | $116.00K | — | $351.00K | — | 03/03/2021 | |
| EVGN | Evogene | -$1.60 | — | -$1.70 | — | $97.00K | $1.90M | $316.00K | -83.37% | 11/18/2020 | 
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% | 
|---|---|---|---|---|
| Q2 | 2025-08-19 | $-0.50 | $-0.63 | 20.6 % | 
| Q1 | 2025-05-21 | $-0.38 | $-0.50 | 24.0 % | 
| Q4 | 2025-03-06 | $0.06 | $-0.73 | 108.2 % | 
| Q3 | 2024-11-21 | $-1.31 | $-1.01 | -29.7 % | 
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% | 
|---|---|---|---|---|
| Q2 | 2025-08-19 | $884.00K | $930.00K | -4.95 % | 
| Q1 | 2025-05-21 | $2.44M | $4.42M | -44.7 % | 
| Q4 | 2025-03-06 | $1.61M | $3.62M | -55.5 % | 
| Q3 | 2024-11-21 | $1.80M | $2.85M | -37.0 % | 
Si prevede che Evogene (EVGN) fornisca risultati il novembre 20, 2025. Gli ultimi risultati sono stati pubblicati il agosto 19, 2025 per il Q2.
L'EPS effettivo era $-0.50, che superato la stima di $-0.63.
Le entrate effettive sono state $884K, che mancato la stima di $930K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.